delirium - Nursing Case Study

Pathophysiology

• Primary mechanism: Neurotransmitter imbalance, particularly acetylcholine deficiency and dopamine excess, disrupts normal brain function, leading to cognitive disturbances that characterize delirium.

• Secondary mechanism: Inflammation and elevated cytokines, often due to underlying illness or infection, contribute to neuronal damage and impaired neurotransmission, exacerbating delirium symptoms.

• Key complication: Delirium can lead to prolonged hospital stays, increased risk of long-term cognitive decline, and higher mortality, emphasizing the need for prompt identification and management.

Patient Profile

Demographics:

68-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Mild Cognitive Impairment

• Current medications: Metformin, Lisinopril, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Acute confusion and agitation

• Key symptoms: Disorientation, difficulty focusing, fluctuating levels of consciousness, agitation, restlessness

• Vital signs: Blood pressure 160/95 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 101.3°F, oxygen saturation 93% on room air

Section 1

As the healthcare team initiates a more comprehensive evaluation of the patient, several initial assessment findings highlight the complexity of his condition. The patient's neurological examination reveals a marked lack of orientation to time and place, with intermittent episodes of agitation and restlessness that are challenging to manage. His speech is incoherent at times, and he demonstrates difficulty in following simple commands, suggesting a significant disruption in cognitive processing. Physical examination notes dry mucous membranes and a decreased skin turgor, indicating possible dehydration, which could be exacerbating his delirium. The patient’s glucose level is elevated at 245 mg/dL, raising concerns about the impact of hyperglycemia on his mental status. Additionally, the presence of a fever and elevated white blood cell count of 14,000/mm³ suggests an infectious process, possibly contributing to the inflammatory cascade and cytokine release involved in worsening delirium.

The team decides to conduct further diagnostic testing to identify potential underlying causes or contributors to the delirium. The initial urine analysis shows significant leukocyte esterase and nitrites, raising suspicion of a urinary tract infection, a common cause of delirium in older adults. A chest X-ray is performed, given the patient's elevated respiratory rate and low oxygen saturation, revealing mild bilateral infiltrates suggestive of early pneumonia. These findings point toward a systemic infection, which aligns with the elevated inflammatory markers noted in the patient's labs. Together, these results contribute to a multifaceted etiology of the delirium, requiring targeted interventions to address both the infectious source and the hydration status.

The healthcare team recognizes the importance of prompt intervention to prevent further complications and potential deterioration of the patient’s cognitive and physical state. Immediate steps include initiating broad-spectrum antibiotics to address the suspected urinary and respiratory infections, adjusting his antihyperglycemic regimen to better control his blood glucose levels, and providing intravenous fluids to correct dehydration. Continuous monitoring of the patient's vital signs and mental status is essential to gauge his response to these interventions and to prevent further escalation of symptoms. This comprehensive approach aims to stabilize the patient, reduce the duration of delirium, and improve overall outcomes, setting the stage for the next phase of his treatment plan.

Section 2

As the team continues to monitor the patient closely following the initiation of interventions, they observe a notable change in his status. Over the next 24 hours, the patient's mental status shows some fluctuation, with brief periods of lucidity followed by episodes of increased confusion and agitation. Vital signs reveal a persistent low-grade fever of 100.5°F despite antibiotic therapy, indicating that the infections are not yet fully controlled. His heart rate remains elevated at 110 beats per minute, and his blood pressure fluctuates between 90/60 mmHg and 100/70 mmHg, suggesting ongoing hemodynamic instability, possibly related to both infection and dehydration.

Lab results show a slight improvement in white blood cell count, now at 12,500/mm³, but his glucose level remains elevated at 220 mg/dL despite adjustments to his antihyperglycemic regimen. The patient's oxygen saturation has improved to 94% on 2 liters of supplemental oxygen, indicating a positive response to the treatment of his respiratory infection. However, the continued presence of dry mucous membranes and only a modest improvement in skin turgor suggest that the dehydration is still not fully corrected, warranting further fluid management.

In light of these findings, the healthcare team decides to refine the treatment strategy. They increase the rate of intravenous fluids and consider the need for a different antibiotic regimen if the patient's fever persists, potentially indicating antibiotic resistance or an atypical infectious organism. They also consult endocrinology to better tailor the glucose management strategy, given the impact of hyperglycemia on cognitive function. This adjustment aims to address the multifaceted contributors to the patient’s delirium, highlighting the importance of individualized care and ongoing reassessment to optimize therapeutic outcomes.

Section 3

As the team continues to monitor the patient, they observe further changes in his clinical status. Over the next 12 hours, the patient experiences worsening agitation and confusion, which now occur more frequently and last longer. While his periods of lucidity are becoming shorter, the healthcare team notes that his speech is increasingly incoherent, and he seems unable to recognize familiar faces, suggesting a deepening of his delirium. Vital signs remain concerning, with his heart rate now rising to 115 beats per minute, and blood pressure dropping to 88/58 mmHg, indicating persistent hemodynamic instability. His respiratory rate has increased to 24 breaths per minute, although oxygen saturation remains stable at 94% on 2 liters of supplemental oxygen.

New diagnostic results reveal a mixed picture. The white blood cell count has decreased slightly to 11,800/mm³, suggesting some response to the ongoing antibiotic therapy, but his C-reactive protein (CRP) level remains elevated at 15 mg/L, indicating persistent inflammation. A repeat renal function panel shows a mild increase in serum creatinine to 1.5 mg/dL, raising concerns about acute kidney injury, possibly due to dehydration or medication effects. In conjunction with endocrinology, adjustments to his diabetes management lead to a slight improvement in glucose control, with current levels at 190 mg/dL. Despite this, the team recognizes that the hyperglycemia may continue to contribute to his cognitive dysfunction.

In response to these developments, the team decides to further escalate fluid resuscitation with isotonic saline to address both dehydration and potential pre-renal azotemia. They also initiate a broader-spectrum antibiotic regimen to cover potential resistant or atypical organisms, given the persistent fever and lack of definitive improvement. The decision is made to conduct a comprehensive medication review to identify any agents that might exacerbate delirium, such as sedatives or anticholinergics. These steps aim to stabilize his hemodynamics, manage the infection more effectively, and mitigate factors contributing to his delirium, underscoring the dynamic and iterative nature of patient-centered care.

Section 4

As the team continues to manage the patient, they reevaluate his status 24 hours after implementing the intensified interventions. The patient shows subtle yet promising changes; his heart rate has decreased slightly to 105 beats per minute, and his blood pressure has improved marginally to 95/60 mmHg. Despite these improvements, his mental status remains a significant concern. He continues to experience fluctuating periods of severe confusion, with only brief intervals of clarity. New neurological assessment findings reveal increased disorientation, with the patient now unable to follow simple commands reliably. His speech remains incoherent, and he exhibits signs of perceptual disturbances, occasionally reaching out to imaginary objects, raising the suspicion of visual hallucinations.

In light of these findings, the team considers potential underlying causes that may be sustaining or exacerbating his delirium. The comprehensive medication review identifies a recently initiated sedative as a possible contributing factor. In consultation with the pharmacist, the team decides to taper and discontinue this medication, opting instead for non-pharmacological strategies to manage agitation, such as ensuring a calm environment and reorienting the patient frequently.

Meanwhile, new laboratory results reveal a further increase in serum creatinine to 1.7 mg/dL, indicating worsening renal function. This prompts a reevaluation of the patient's fluid status and potential nephrotoxic medications. The team reassesses his fluid management plan, deciding to adjust the rate of isotonic saline administration to optimize renal perfusion without overloading his cardiovascular system. These decisions highlight the complexity of managing delirium in the context of multi-system involvement, requiring careful clinical reasoning to balance interventions and mitigate evolving complications. The team remains vigilant, recognizing that ongoing assessment and adjustment are crucial to navigating the patient's intricate clinical trajectory.

Section 5

Two days following the adjustment in the patient's medication regimen and fluid management plan, there is a noticeable change in his status. His heart rate has stabilized further, now consistently measuring at 98 beats per minute, and his blood pressure has increased slightly to 100/65 mmHg. However, his mental status remains erratic. The patient exhibits prolonged periods of lethargy, punctuated by episodes of pronounced agitation and restlessness. His ability to communicate remains impaired, with speech that is largely incoherent and often irrelevant to the context. The presence of visual hallucinations persists, and he now exhibits auditory hallucinations, frequently responding to unheard voices.

New diagnostic results indicate a significant electrolyte imbalance, with serum sodium levels decreasing to 128 mEq/L, suggestive of hyponatremia. This new complication prompts the team to reconsider the patient's fluid and electrolyte management strategy. They hypothesize that the adjustments in fluid administration, aimed at improving renal function, may have inadvertently contributed to this imbalance. The team decides to cautiously introduce hypertonic saline under close monitoring, aiming to correct the sodium levels gradually to avoid further neurological deterioration. This decision underscores the delicate balance required in managing the interconnected systems involved in delirium and highlights the necessity for ongoing vigilance and adaptability in care strategies.

The team remains acutely aware of the potential for additional complications, given the patient's complex presentation. As they continue to monitor his response to the revised interventions, they plan for a multidisciplinary meeting to explore potential underlying causes for his prolonged delirium and to ensure that all possible contributing factors are addressed. The evolving case challenges the team to integrate new information and adjust their approach continually, underscoring the dynamic nature of clinical reasoning in managing patients with multifaceted health issues.